# Corrigendum to “Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer – efficacy, tolerability and quality of life results from the phase II METRO trial” [The Breast 78 (2004) 103795]

**Authors:** Karolina Larsson F, Jamila Adra, Leif Klint, Barbro Linderholm

PMC · DOI: 10.1016/j.breast.2025.104420 · The Breast : Official Journal of the European Society of Mastology · 2025-03-13

## Full-text entities

- **Diseases:** breast cancer (MESH:D001943)
- **Chemicals:** capecitabine (MESH:D000069287), cyclophosphamide (MESH:D003520)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11973820/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11973820/full.md

---
Source: https://tomesphere.com/paper/PMC11973820